{
  "title": "Cancer Pain Management",
  "lastUpdated": "2024-01-15",
  "sections": [
    {
      "type": "header",
      "level": 1,
      "content": "Cancer Pain Management"
    },
    {
      "type": "text",
      "content": "Cancer pain affects 70-90% of patients with advanced cancer. Effective pain management is achievable in >90% of patients with appropriate assessment and treatment."
    },
    {
      "type": "header",
      "level": 2,
      "content": "WHO Analgesic Ladder"
    },
    {
      "type": "table",
      "headers": ["Step", "Pain Level", "Medications", "Adjuvants"],
      "rows": [
        ["Step 1", "Mild (1-3/10)", "Non-opioids (acetaminophen, NSAIDs)", "Consider adjuvants"],
        ["Step 2", "Moderate (4-6/10)", "Weak opioids + non-opioids", "Add adjuvants"],
        ["Step 3", "Severe (7-10/10)", "Strong opioids Â± non-opioids", "Continue adjuvants"]
      ]
    },
    {
      "type": "header",
      "level": 2,
      "content": "Opioid Conversion Guidelines"
    },
    {
      "type": "list",
      "items": [
        "**Morphine to Oxycodone**: 1:0.67 ratio (reduce by 33%)",
        "**Morphine to Fentanyl**: Calculate 24h morphine, divide by 2 for mcg/h patch",
        "**Oral to IV Morphine**: 3:1 ratio (reduce by 67% for IV)",
        "**Cross-tolerance**: Reduce calculated dose by 25-50% when switching"
      ]
    },
    {
      "type": "callout",
      "calloutType": "warning",
      "content": "**Safety Alert**: Always reduce calculated equianalgesic dose by 25-50% when rotating opioids to account for incomplete cross-tolerance."
    },
    {
      "type": "header",
      "level": 2,
      "content": "Breakthrough Pain Management"
    },
    {
      "type": "list",
      "items": [
        "**Dose**: 10-20% of 24-hour opioid requirement",
        "**Frequency**: Every 1-2 hours as needed",
        "**Onset**: Immediate-release formulations preferred",
        "**Assessment**: If >4 doses/day needed, increase baseline dose"
      ]
    },
    {
      "type": "header",
      "level": 2,
      "content": "Adjuvant Medications"
    },
    {
      "type": "table",
      "headers": ["Pain Type", "First-Line Adjuvant", "Dose Range", "Notes"],
      "rows": [
        ["Neuropathic", "Gabapentin", "300-3600 mg/day", "Titrate slowly"],
        ["Bone Pain", "Bisphosphonates", "Varies by agent", "Consider radiation"],
        ["Muscle Spasm", "Baclofen", "5-80 mg/day", "Start low, titrate"],
        ["Inflammation", "Dexamethasone", "4-16 mg/day", "Limited duration"]
      ]
    },
    {
      "type": "callout",
      "calloutType": "tip",
      "content": "**Clinical Pearl**: Neuropathic pain often requires combination therapy with opioids plus adjuvant medications for optimal control."
    }
  ]
}
